FR2205307A1 - Luteal hormone-releasing hormone prepns - for treatment of hypothalamus insufficiency by intranasal admin. - Google Patents

Luteal hormone-releasing hormone prepns - for treatment of hypothalamus insufficiency by intranasal admin.

Info

Publication number
FR2205307A1
FR2205307A1 FR7339235A FR7339235A FR2205307A1 FR 2205307 A1 FR2205307 A1 FR 2205307A1 FR 7339235 A FR7339235 A FR 7339235A FR 7339235 A FR7339235 A FR 7339235A FR 2205307 A1 FR2205307 A1 FR 2205307A1
Authority
FR
France
Prior art keywords
hormone
prepns
hypothalamus
treatment
insufficiency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7339235A
Other languages
English (en)
French (fr)
Other versions
FR2205307B1 (bs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Farbwerke Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG, Farbwerke Hoechst AG filed Critical Hoechst AG
Publication of FR2205307A1 publication Critical patent/FR2205307A1/fr
Application granted granted Critical
Publication of FR2205307B1 publication Critical patent/FR2205307B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7339235A 1972-11-04 1973-11-05 Luteal hormone-releasing hormone prepns - for treatment of hypothalamus insufficiency by intranasal admin. Granted FR2205307A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2254061A DE2254061A1 (de) 1972-11-04 1972-11-04 Lh-releasing hormon zur nasalen applikation

Publications (2)

Publication Number Publication Date
FR2205307A1 true FR2205307A1 (en) 1974-05-31
FR2205307B1 FR2205307B1 (bs) 1977-09-09

Family

ID=5860838

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7339235A Granted FR2205307A1 (en) 1972-11-04 1973-11-05 Luteal hormone-releasing hormone prepns - for treatment of hypothalamus insufficiency by intranasal admin.

Country Status (7)

Country Link
AT (1) AT330962B (bs)
BE (1) BE806912A (bs)
CA (1) CA1014471A (bs)
DE (1) DE2254061A1 (bs)
FR (1) FR2205307A1 (bs)
NL (1) NL7314883A (bs)
ZA (1) ZA738460B (bs)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0242643A2 (en) * 1986-04-23 1987-10-28 Fisons Corporation Nasal administration of drugs
EP0275404A1 (en) * 1986-11-25 1988-07-27 Abbott Laboratories LHRH analog formulations
EP0289336A2 (en) * 1987-04-30 1988-11-02 Cooper Laboratories Aerosolization of protein therapeutic agent

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL70489A0 (en) * 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2108007A1 (bs) * 1970-09-26 1972-05-12 Organon Nv
DE2306075A1 (de) * 1972-02-17 1973-08-23 Ciba Geigy Ag Injizierbare oelige peptidpraeparate und verfahren zu ihrer herstellung

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2108007A1 (bs) * 1970-09-26 1972-05-12 Organon Nv
DE2306075A1 (de) * 1972-02-17 1973-08-23 Ciba Geigy Ag Injizierbare oelige peptidpraeparate und verfahren zu ihrer herstellung

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0242643A2 (en) * 1986-04-23 1987-10-28 Fisons Corporation Nasal administration of drugs
EP0242643A3 (en) * 1986-04-23 1988-04-06 Delaware Chemicals Corporation Nasal administration of drugs
EP0275404A1 (en) * 1986-11-25 1988-07-27 Abbott Laboratories LHRH analog formulations
EP0510731A1 (en) * 1986-11-25 1992-10-28 Abbott Laboratories LHRH Analog formulations
EP0289336A2 (en) * 1987-04-30 1988-11-02 Cooper Laboratories Aerosolization of protein therapeutic agent
EP0289336A3 (en) * 1987-04-30 1989-10-11 Cooper Laboratories Aerosolization of protein therapeutic agent
US5618786A (en) * 1987-04-30 1997-04-08 Cooper Laboratories, Inc. Aerosolization of protein therapeutic agent

Also Published As

Publication number Publication date
ATA925173A (de) 1975-10-15
DE2254061A1 (de) 1974-05-16
AU6215973A (en) 1975-05-08
AT330962B (de) 1976-07-26
FR2205307B1 (bs) 1977-09-09
BE806912A (fr) 1974-05-06
NL7314883A (bs) 1974-05-07
ZA738460B (en) 1974-10-30
CA1014471A (en) 1977-07-26

Similar Documents

Publication Publication Date Title
CA964469A (en) Water-in-oil emulsion type blasting agent
SE7412792L (bs)
IT943649B (it) Procedimento per la preparazione simultanea di i 3 butadiene e metacroleina
FR2205307A1 (en) Luteal hormone-releasing hormone prepns - for treatment of hypothalamus insufficiency by intranasal admin.
GB1280322A (en) Aircraft ejection seat mechanisms
FR2205308A1 (en) Luteal hormone-releasing hormone prepns - for treatment of hypothalamus insufficiency by intranasal admin.
ES397417A1 (es) Metodo para hinchar tabaco.
CA626987A (en) Combined thrust reversing and noise suppressing device for turbo-jet engines
FR2032598A5 (en) Continuous fermentation of molasses and - other alcohol formers
FR2106984A5 (en) Honey and butter foodstuff - with added vitamins and butter preservative
FR1039278A (fr) Frein à commande hydraulique et à air sous pression, notamment pour les véhiculesautomobiles
GB738818A (en) Improvements relating to coffee preparations and to preparations for use therewith
GB999705A (en) Improvements in or relating to crop guides
ES88987Y (es) Envase hermético de un solo uso para bebidas refrescantes y sorbetes
Nouera A study of Egyptian folk games and theiur adaptation for recreational use
RHEINWALD Studies on the influence of Pervitin on the incidence of gas bubbles in blood after decompression(Influence of Pervitin in decreasing gas bubbles in blood during decompression)
FR2104239A5 (en) Chocolate spread - consisting of a mixture of chocolate and stewed dates
Pei Etruscan and Indo-European Case-Endings
CA742885A (en) Method and device for examining the physiological condition of cellular tissues
新関暢一 NEEES
ES212470Y (es) Dispositivo manual para el rectificado simultaneo de asien-tos de valvula.
FR2147039A1 (en) Stilboestrol dicarbamate deriv - for treatment of prostata careinomas
AU134915B2 (en) Improvement in engine starter and generator means
NL168597B (nl) Afsluiter voor sanitaire doeleinden, alsmede daarvoor bestemd afsluiterhuis.
AU464479B2 (en) Water-in-oil emulsion type blasting agent

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse